Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS)

Sorafenib is the only standard treatment for unresectable hepatocellular carcinoma (HCC), but it provides modest survival benefits over placebo, necessitating predictive biomarkers of the response to sorafenib. Serum samples were obtained from 115 consecutive patients with HCC before sorafenib treat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cell Proteomics
Main Authors: Kim, Hyunsoo, Yu, Su Jong, Yeo, Injun, Cho, Young Youn, Lee, Dong Hyeon, Cho, Yuri, Cho, Eun Ju, Lee, Jeong-Hoon, Kim, Yoon Jun, Lee, Sungyoung, Jun, Jongsoo, Park, Taesung, Yoon, Jung-Hwan, Kim, Youngsoo
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society for Biochemistry and Molecular Biology 2017
Assuntos:
Technological Innovation and Resources
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5500763/
https://ncbi.nlm.nih.gov/pubmed/28550167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.M116.066704
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados